OraSure, OraQuick Hepatitis C antibody, Point of Care test (Ангилья - Тендер #39233064)

• Contract award notice

Results of the procurement procedure

Section I: Contracting entity I.1) Name and addresses

NHS Wales Shared Services Partnership

2 Capital Quarter, Tyndall Street

Cardiff

CF10 4BZ

UK

Contact person: Nadine Stokes

Telephone: +44 2920902253

E-mail: nadine.stokes@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://nwssp.nhs.wales/ourservices/procurement-services/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object II.1) Scope of the procurement II.1.1) Title

OraSure, OraQuick Hepatitis C antibody, Point of Care test

II.1.2) Main CPV code

38912000

II.1.3) Type of contract

Supplies

II.1.4) Short description

OraSure, OraQuick Hepatitis C antibody, Point of Care test

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description II.2.3) Place of performance

NUTS code:

UKL

Main site or place of performance:

All Wales

II.2.4) Description of the procurement

OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity

II.2.5) Award criteria

Quality criterion: As per procurement documents / Weighting: 100

Price / Weighting: 0

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure IV.1) Description IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation

The OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity.

There are no alternative suppliers who have the CE marked technology for the OraQuick HCV rapid antibody test.

As such, there are no identified alternative suppliers who can complete all of the following elements as one test:

- The OraQuick HCV rapid antibody test plus absorbent packet

- An OraQuick HCV developer solution (0.75ml phosphate buffered saline solution containing polymers and a antimicrobial agent)

- Reusable test stands

- Collection loops

- Package insert

- Rapid HCV results ready in 20-40 minutes

- The OraQuick HCV test comes with quality control reagents include:

- When each new operator is using the kit

- Whenever a new test it lot is opened

- Whenever the kit storage area falls outside of 2C-30C

- Whenever the kit testing area fall outside of 15C-37C

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2023/S 000-007677

Section V: Award of contract

Contract No: N/a

A contract/lot is awarded: No

V.1 Information on non-award

The contract/lot is not awarded

Other reasons (discontinuation of procedure)

Section VI: Complementary information VI.3) Additional information

1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.

(WA Ref:130046)

VI.4) Procedures for review VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

NHS Wales Shared Services Partnership on behalf of Public Health Wales NHS Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.

Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful.

Should additional information be required it should be requested of the addressee in section I.1.

Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015

VI.5) Date of dispatch of this notice

16/03/2023

Information added to the notice since publication.

Additional information added to the notice since it"s publication.

Источник закупки

Перейти

Импорт - Экспорт по стране Ангилья